Literature DB >> 11987988

Abnormal B cell differentiation in primary Sjögren's syndrome results in a depressed percentage of circulating memory B cells and elevated levels of soluble CD27 that correlate with Serum IgG concentration.

Janne Ø Bohnhorst1, Marie B Bjørgan, Jørn E Thoen, Roland Jonsson, Jacob B Natvig, Keith M Thompson.   

Abstract

The percentage of CD27(+) B cells in peripheral blood (PB) of patients with primary Sjögren's syndrome (pSS) is significantly decreased compared to normals. In contrast, serum levels of the soluble form of CD27 (sCD27) are significantly higher in pSS patients, with a strong positive correlation between sCD27 and serum IgG levels. In vitro experiments demonstrate that normal B cells cultured under conditions driving plasma cell differentiation result in the production of substantial amounts of sCD27. Analyses of V(H)-region genes from sorted CD27(+) and CD27(-) B cells from pSS patients confirm that the CD27(+) population corresponds to the somatically mutated memory compartment, as in healthy individuals. Together our data indicate that in pSS, there is an abnormal differentiation of B cells to plasma cells resulting in a depression of the circulating memory B-cell pool and the release of significant amounts of sCD27 and IgG.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11987988     DOI: 10.1006/clim.2002.5199

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  24 in total

Review 1.  Recent advances in understanding molecular mechanisms in the pathogenesis and antibody profile of Sjögren's syndrome.

Authors:  Roland Jonsson; Tom P Gordon; Yrjö T Konttinen
Journal:  Curr Rheumatol Rep       Date:  2003-08       Impact factor: 4.592

2.  A comprehensive investigation on the distribution of circulating follicular T helper cells and B cell subsets in primary Sjögren's syndrome and systemic lupus erythematosus.

Authors:  K Szabó; G Papp; A Szántó; T Tarr; M Zeher
Journal:  Clin Exp Immunol       Date:  2015-10-21       Impact factor: 4.330

3.  Primary Sjögren's syndrome is characterized by distinct phenotypic and transcriptional profiles of IgD+ unswitched memory B cells.

Authors:  Mustimbo E P Roberts; Denise Kaminski; Scott A Jenks; Craig Maguire; Kathryn Ching; Peter D Burbelo; Michael J Iadarola; Alexander Rosenberg; Andreea Coca; Jennifer Anolik; Iñaki Sanz
Journal:  Arthritis Rheumatol       Date:  2014-09       Impact factor: 10.995

4.  Defective Early B Cell Tolerance Checkpoints in Sjögren's Syndrome Patients.

Authors:  Salomé Glauzy; Joel Sng; Jason M Bannock; Jacques-Eric Gottenberg; Anne-Sophie Korganow; Patrice Cacoub; David Saadoun; Eric Meffre
Journal:  Arthritis Rheumatol       Date:  2017-10-12       Impact factor: 10.995

5.  Soluble levels of CD27 and CD30 are associated with risk of non-Hodgkin lymphoma in three Chinese prospective cohorts.

Authors:  Bryan A Bassig; Xiao-Ou Shu; Woon-Puay Koh; Yu-Tang Gao; Mark P Purdue; Lesley M Butler; Jennifer Adams-Haduch; Yong-Bing Xiang; Troy J Kemp; Renwei Wang; Ligia A Pinto; Tongzhang Zheng; Bu-Tian Ji; H Dean Hosgood; Wei Hu; Gong Yang; Heping Zhang; Wong-Ho Chow; Christopher Kim; Wei Jie Seow; Wei Zheng; Jian-Min Yuan; Qing Lan; Nathaniel Rothman
Journal:  Int J Cancer       Date:  2015-06-26       Impact factor: 7.396

6.  A case of reactive plasmacytosis mimicking multiple myeloma in a patient with primary Sjogren's syndrome.

Authors:  Jisoo Lee; Ji-Eun Chang; Young-Joo Cho; Woon Seop Han
Journal:  J Korean Med Sci       Date:  2005-06       Impact factor: 2.153

Review 7.  B-lymphocyte tolerance and effector function in immunity and autoimmunity.

Authors:  Wasif N Khan; Jacqueline A Wright; Eden Kleiman; Justin C Boucher; Iris Castro; Emily S Clark
Journal:  Immunol Res       Date:  2013-12       Impact factor: 2.829

8.  Diminished CXCR5 expression in peripheral blood of patients with Sjögren's syndrome may relate to both genotype and salivary gland homing.

Authors:  L A Aqrawi; M Ivanchenko; A Björk; J I Ramírez Sepúlveda; J Imgenberg-Kreuz; M Kvarnström; P Haselmayer; J L Jensen; G Nordmark; K Chemin; K Skarstein; M Wahren-Herlenius
Journal:  Clin Exp Immunol       Date:  2018-03-24       Impact factor: 4.330

9.  Interferon-β therapy specifically reduces pathogenic memory B cells in multiple sclerosis patients by inducing a FAS-mediated apoptosis.

Authors:  Fabiana Rizzo; Elena Giacomini; Rosella Mechelli; Maria Chiara Buscarinu; Marco Salvetti; Martina Severa; Eliana Marina Coccia
Journal:  Immunol Cell Biol       Date:  2016-06-06       Impact factor: 5.126

10.  Ro52- and Ro60-specific B cell pattern in the salivary glands of patients with primary Sjögren's syndrome.

Authors:  L A Aqrawi; K Skarstein; G Øijordsbakken; K A Brokstad
Journal:  Clin Exp Immunol       Date:  2013-05       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.